Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
UCLA’s Drs. Chelsea Shover & David Goodman-Meza featured in LA Times Article
CBAM’s Mobile Clinic featured in LA Times article
Methamphetamine use and adoption of preventive behaviors early in the COVID-19 pandemic among men who have sex with men in Los Angeles, California
UCLA Vine Street Clinic and Mobile Unit Open House
Peer Ambassadors Can Be Used to Increase Coronavirus Vaccination Among Unsheltered Angelenos


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.